The long-term goal of this research is to understand the biochemical mechanism of human amyloid disease, such that novel mechanism-based small molecule and macromolecular therapeutic strategies can be developed. It is now possible to prepare and isolate hybrid transthyretin (TTR) tetramers of defined subunit composition, reflecting those found in heterozygous familial amyloid polyneuropathy patients.
In aim 1, the kinetics and thermodynamics of denaturation and amyloidogenicity of the hybrid tetramers will be evaluated as a function of added binding partners and a variety of physiologically relevant conditions to better understand the mechanistic features of amyloidogenesis. The feasibility of a trans-suppression approach for therapeutic intervention will be evaluated, and in related studies, the idea that only certain hybrid tetramers will be amenable to fibril formation at a given denaturation stress level, will be tested. A folded monomeric version of TTR enables the kinetics and thermodynamics of the amyloidogenic tertiary structural changes to be studied independent of the quaternary structural changes. Several hypotheses will be tested, including the idea that amyloid fibrils derived from different sequences have unique quaternary structures. A structure-based design approach for discovering small molecule inhibitors of TTR amyloid fibril formation will be expanded in aim 2 to develop bivalent inhibitors, in an effort to test the amyloid hypothesis in vitro, in cell lines and in a murine animal model in vivo. The kinetics of binding and dissociation of the best structurally diverse inhibitors will be evaluated to better understand their efficacy.
In aim 3, the mechanistic connection between amyloidogenesis and the neuropathology characterizing these diseases will be sought. Efficient intralysosomal amyloid formation is observed in a macrophage cell line fed L55P TTR, but not WT TTR. The decreased viability of the cells converting soluble L55P into amyloid allows the use of expression profiling and protein analysis to understand how it is that amyloidosis reprograms the cell for demise. The idea that a rare cell secreting amyloid fibrils (or a lysed amyloid laden cell) could infect cells in its vicinity leading to the rapid onset of disease will be explored also.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK046335-11
Application #
6478412
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Program Officer
Rasooly, Rebekah S
Project Start
1993-05-01
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
11
Fiscal Year
2002
Total Cost
$411,622
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Monteiro, Cecilia; Martins da Silva, Ana; Ferreira, Natália et al. (2018) Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients. Amyloid 25:120-128
Buxbaum, Joel N; Morgan, Gareth J (2018) Summary: FASEB Science Research Conference on Protein Aggregation in Health and Disease. FASEB J 32:1125-1129
Rennella, Enrico; Morgan, Gareth J; Kelly, Jeffery W et al. (2018) Role of domain interactions in the aggregation of full-length immunoglobulin light chains. Proc Natl Acad Sci U S A :
Mortenson, David E; Brighty, Gabriel J; Plate, Lars et al. (2018) ""Inverse Drug Discovery"" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates. J Am Chem Soc 140:200-210
Sperry, Brett W; Reyes, Bryan A; Ikram, Asad et al. (2018) Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. J Am Coll Cardiol 72:2040-2050
Lampkin, Bryan J; Monteiro, Cecilia; Powers, Evan T et al. (2018) A designed protein binding-pocket to control excited-state intramolecular proton transfer fluorescence. Org Biomol Chem :
Madhivanan, Kayalvizhi; Greiner, Erin R; Alves-Ferreira, Miguel et al. (2018) Cellular clearance of circulating transthyretin decreases cell-nonautonomous proteotoxicity in Caenorhabditis elegans. Proc Natl Acad Sci U S A 115:E7710-E7719
Leach, Benjamin I; Zhang, Xin; Kelly, Jeffery W et al. (2018) NMR Measurements Reveal the Structural Basis of Transthyretin Destabilization by Pathogenic Mutations. Biochemistry 57:4421-4430
Chen, Kai-Chun; Qu, Song; Chowdhury, Saikat et al. (2017) The endoplasmic reticulum HSP40 co-chaperone ERdj3/DNAJB11 assembles and functions as a tetramer. EMBO J 36:2296-2309
Schonhoft, Joseph D; Monteiro, Cecilia; Plate, Lars et al. (2017) Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients. Sci Transl Med 9:

Showing the most recent 10 out of 61 publications